Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP338882.RADR1vTqh20TSu2EEALVv8xW7RJAeAwrOyooqU2Ntbjwg130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338882.RADR1vTqh20TSu2EEALVv8xW7RJAeAwrOyooqU2Ntbjwg130_provenance.
• NP482910.RAXdJYtlbg_6HI95-kwUuhT_vwxpKYB7tvijzhQjWXkPg130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482910.RAXdJYtlbg_6HI95-kwUuhT_vwxpKYB7tvijzhQjWXkPg130_provenance.
• NP528612.RASzD9d0Aa6x5YyMqCLW-5XkjFGtOFNRgPDfUcio9G7xs130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528612.RASzD9d0Aa6x5YyMqCLW-5XkjFGtOFNRgPDfUcio9G7xs130_provenance.
• NP566093.RAdnox9WMOj20PR7nlat0F4nELxnlrSQLojADU_bgSjX8130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566093.RAdnox9WMOj20PR7nlat0F4nELxnlrSQLojADU_bgSjX8130_provenance.
• NP832010.RAXl8gSbEg4_91EK1ADGq884PXICIfFATivcM8IgGcTrw130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP832010.RAXl8gSbEg4_91EK1ADGq884PXICIfFATivcM8IgGcTrw130_provenance.
• NP888330.RAlMHll8022FWVW0RU-XQ4V_sX9unP7AtC-Z11L115iUU130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888330.RAlMHll8022FWVW0RU-XQ4V_sX9unP7AtC-Z11L115iUU130_provenance.
• NP930208.RAi_AQ-jfkN7EcS6AlfpHvFLi3_j2BCwXRlRVbazRacFQ130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930208.RAi_AQ-jfkN7EcS6AlfpHvFLi3_j2BCwXRlRVbazRacFQ130_provenance.
• NP387978.RADA0x13lDGaO8jVK6ccuAK_YRrKEqDfZxW47V7bjjh3M130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387978.RADA0x13lDGaO8jVK6ccuAK_YRrKEqDfZxW47V7bjjh3M130_provenance.
• NP351149.RAUI0zw1VlWhH8P0kRdgy1IjlYkjt4IWBV9xM0W1f3tks130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP351149.RAUI0zw1VlWhH8P0kRdgy1IjlYkjt4IWBV9xM0W1f3tks130_provenance.
• NP870058.RARjsrC0Aijv1rljvWvkxUKokUq7gRzZaw_wtWxUDkbQs130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870058.RARjsrC0Aijv1rljvWvkxUKokUq7gRzZaw_wtWxUDkbQs130_provenance.
• NP706389.RAYZTnITWXOsZavC4HnjQ079MbWAHUzCYWeuJWqp7T7DU130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP706389.RAYZTnITWXOsZavC4HnjQ079MbWAHUzCYWeuJWqp7T7DU130_provenance.
• NP435323.RAzgAet44l54hps7jfnYF7pXHt5OqCz7QWdfL9nZjtoNo130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435323.RAzgAet44l54hps7jfnYF7pXHt5OqCz7QWdfL9nZjtoNo130_provenance.
• NP452021.RA4A3bAtaFtDBRWXCr44VGfUn95BqWDLGc7o-QZqP3GdE130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452021.RA4A3bAtaFtDBRWXCr44VGfUn95BqWDLGc7o-QZqP3GdE130_provenance.
• NP312668.RA_mvH4kWJM1lA8uL1Rdi5-qukdTH8n4bHVJudrIfEgy8130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP312668.RA_mvH4kWJM1lA8uL1Rdi5-qukdTH8n4bHVJudrIfEgy8130_provenance.
• NP343519.RAVGeEMIcCPPoX5T0bulpTNNLEk3xvThlbmlnBIq4l6eA130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343519.RAVGeEMIcCPPoX5T0bulpTNNLEk3xvThlbmlnBIq4l6eA130_provenance.
• NP343692.RATW2_JVCxCXdcEXSOYdvnOE7sHyfpQvq_nDKRCT3lckU130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343692.RATW2_JVCxCXdcEXSOYdvnOE7sHyfpQvq_nDKRCT3lckU130_provenance.
• NP496296.RAOAmVNXgQ9d6QwerZ0Y-PEEoSdIOOweLu4VjmGLXw99o130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496296.RAOAmVNXgQ9d6QwerZ0Y-PEEoSdIOOweLu4VjmGLXw99o130_provenance.
• NP347179.RABmQhBJldAg2X9a24DE6JWBCvWcoRktUUX93psquhMmA130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347179.RABmQhBJldAg2X9a24DE6JWBCvWcoRktUUX93psquhMmA130_provenance.
• NP347181.RAAoPQONTGygr-mDBb5qVkx2WKC-osjBP2M6YTPBH8oMU130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347181.RAAoPQONTGygr-mDBb5qVkx2WKC-osjBP2M6YTPBH8oMU130_provenance.
• NP347187.RACP4dkd9PUN8LFl0HQ-Wo0jQO1hF5RfsxpnG25P3Rmfk130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347187.RACP4dkd9PUN8LFl0HQ-Wo0jQO1hF5RfsxpnG25P3Rmfk130_provenance.
• NP347188.RACYYvpD1SKSQTNNVkH8ZQ9JnvD3aPiS6cgE0GoIr9cXY130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347188.RACYYvpD1SKSQTNNVkH8ZQ9JnvD3aPiS6cgE0GoIr9cXY130_provenance.
• NP347178.RAYcyzokz6MysP2_JSuRutWpgPQXAG9ph73ruZdKWuQ8w130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347178.RAYcyzokz6MysP2_JSuRutWpgPQXAG9ph73ruZdKWuQ8w130_provenance.
• NP347180.RAeC-sCuTjTIMCW9rXI3pmIPRTeNgkQB5ZGeOyfW4-vt4130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347180.RAeC-sCuTjTIMCW9rXI3pmIPRTeNgkQB5ZGeOyfW4-vt4130_provenance.
• NP347182.RAYf7TsN53KKQ_hSZUjJd6Znuzv8HmN74klMFxNuYaFk0130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347182.RAYf7TsN53KKQ_hSZUjJd6Znuzv8HmN74klMFxNuYaFk0130_provenance.
• NP347183.RAXjbWMo-Q8Lc8LrJaj8s1rbs1LsP-Q5atc_9ucMicHjM130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347183.RAXjbWMo-Q8Lc8LrJaj8s1rbs1LsP-Q5atc_9ucMicHjM130_provenance.
• NP347192.RAVr7orXshLisdwne6yPgc2OpIYL34LS0KALGlB98Cf0Q130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347192.RAVr7orXshLisdwne6yPgc2OpIYL34LS0KALGlB98Cf0Q130_provenance.
• assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP442621.RAh2HcaTx-189TREewqTv8n6d23X-bcurTM9uIZSirSqQ130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442621.RAh2HcaTx-189TREewqTv8n6d23X-bcurTM9uIZSirSqQ130_provenance.
• NP1013142.RAnLzUbm_jmYiX9jOvygQPM451a-jOzIL1iPvoAkLqFu4130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1013142.RAnLzUbm_jmYiX9jOvygQPM451a-jOzIL1iPvoAkLqFu4130_provenance.
• NP1013147.RAgjyIKXethYD1du3pf5_szO3htdRSDY_NMI1vHVow5H0130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1013147.RAgjyIKXethYD1du3pf5_szO3htdRSDY_NMI1vHVow5H0130_provenance.
• NP694904.RArlwugGYF8vgr2fFELNvWUX9EDQlsHvcgD_l6ayFRQ5I130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694904.RArlwugGYF8vgr2fFELNvWUX9EDQlsHvcgD_l6ayFRQ5I130_provenance.
• NP812785.RAk0pHKqnUa-Z6UEdoL5k8BfPOstk7G6ZwlWODZ-5IaLE130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812785.RAk0pHKqnUa-Z6UEdoL5k8BfPOstk7G6ZwlWODZ-5IaLE130_provenance.
• NP812792.RAjHN7deTIbd0h9VoNZjWDVMiVd1xn5fAUCBJQhog6uko130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812792.RAjHN7deTIbd0h9VoNZjWDVMiVd1xn5fAUCBJQhog6uko130_provenance.
• NP347186.RAkYrTzhOyx-xfrBTzCgeFexHjO5lFgBHgiEehUJM70uU130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347186.RAkYrTzhOyx-xfrBTzCgeFexHjO5lFgBHgiEehUJM70uU130_provenance.
• NP347189.RAtRAS3gyy3Qj_Ob686P43kqsl03SOYLyRLj7LFKZ924c130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347189.RAtRAS3gyy3Qj_Ob686P43kqsl03SOYLyRLj7LFKZ924c130_provenance.
• NP347191.RAvGWd1NPsFiG2_KhGgT1u8BaAnymPLG_ImnJqOfpzLtY130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347191.RAvGWd1NPsFiG2_KhGgT1u8BaAnymPLG_ImnJqOfpzLtY130_provenance.
• NP442658.RAKOIMVLOdNwAtoi4NcO1TcNeVLzFhG4Pozjo60RvLOi8130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442658.RAKOIMVLOdNwAtoi4NcO1TcNeVLzFhG4Pozjo60RvLOi8130_provenance.
• NP442740.RAMPsFetHgI7OAIXHYxGjPXqZouxlwuZCyezQvJYJN5lM130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442740.RAMPsFetHgI7OAIXHYxGjPXqZouxlwuZCyezQvJYJN5lM130_provenance.
• NP812813.RAPTGzFGZkhF72L7DgzHDPYhF_J4exUnP0L2AXOCeCrII130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812813.RAPTGzFGZkhF72L7DgzHDPYhF_J4exUnP0L2AXOCeCrII130_provenance.
• NP347185.RANPBgo1yjc3d4uqvYDcoof4KploA5Zu-0el1v4cs75KE130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347185.RANPBgo1yjc3d4uqvYDcoof4KploA5Zu-0el1v4cs75KE130_provenance.
• NP343465.RAFCjduuBE2XeZYO7WWHetsHUZaCeOAXDTbnd6sfdj6kA130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343465.RAFCjduuBE2XeZYO7WWHetsHUZaCeOAXDTbnd6sfdj6kA130_provenance.
• NP694890.RAMvDop9id23YJAKur-qICeC8Kx68oGOLjr2aUcSN-nmE130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694890.RAMvDop9id23YJAKur-qICeC8Kx68oGOLjr2aUcSN-nmE130_provenance.
• NP694896.RAEIEWAsC8B3JCRJhS4ch1lu-bfPquUK5PpNVzlRu6E-s130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694896.RAEIEWAsC8B3JCRJhS4ch1lu-bfPquUK5PpNVzlRu6E-s130_provenance.
• NP1013145.RA4QhDkC_d9oYS1RGvUGv11HdvnoUxj934sthjI2HeSuo130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1013145.RA4QhDkC_d9oYS1RGvUGv11HdvnoUxj934sthjI2HeSuo130_provenance.
• NP347190.RAyew0-pFWxr0I5lSiQs9-Ozng1pAfJiq1wX9SqnLlOAk130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347190.RAyew0-pFWxr0I5lSiQs9-Ozng1pAfJiq1wX9SqnLlOAk130_provenance.
• NP347193.RA7AF_KNOE-jv6rqofCHCVybMbSZSUwlMo8KK-XKmLgZQ130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347193.RA7AF_KNOE-jv6rqofCHCVybMbSZSUwlMo8KK-XKmLgZQ130_provenance.